Rhythm Pharmaceuticals (RYTM) Deferred Taxes (2021)

Rhythm Pharmaceuticals (RYTM) reported Deferred Taxes of -$9.0 million for Q3 2021, down 79.11% quarter-over-quarter from -$5.0 million in Q2 2021.

Rhythm Pharmaceuticals (RYTM) Deferred Taxes (2021) Analysis & Trends

Rhythm Pharmaceuticals (RYTM) has 1 years of Deferred Taxes data on file, last reported at -$9.0 million in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-859,000.00
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-65.30 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Rhythm Pharmaceuticals	6.59 Bn	6.25 Bn	52.96 Mn	-

Download Data